Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2018 R43 PAR-18-303 SCHOETTLE, LOUIS GEMNEO BIOSCIENCE, INC. Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes Complete
1999 R43 PAR-98-066 RICHTERICH, PETER CODONCODE CORPORATION SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION Complete
2002 R21 PAR-01-104 YEUNG, EDWARD S. IOWA STATE UNIVERSITY SINGLE-MOLECULE IMMUNOASSAY AND DNA SCREENING Complete
2005 R21 RFA-CA-05-002 WANG, BINGHE GEORGIA STATE UNIVERSITY FLUORESCENT APTAMERS FOR GLYCOPROTEIN DETECTION Complete
2008 R21 RFA-CA-07-022 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY SURROGATE AND SENTINAL TECHNOLOGIES TO MONITOR STABILITY OF CANCER PHOSPHOPROTEIN Complete
2010 R44 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2015 R21 RFA-CA-14-003 ELLINGTON, ANDREW D UNIVERSITY OF TEXAS, AUSTIN HIGH THROUGHPUT SINGLE CELL TRANSCRIPTOME ANALYSIS Complete
2017 R44 PAR-13-327 PREMSRIRUT, PREM KHOVABUTR MIRIMUS, INC. Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research Complete
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2007 R21 RFA-CA-07-003 ROGERS, RICK HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) SAMPLE PREP METHODS TO ALLOW AUTOMATED 3D ANALYSIS OF MICROVESSEL MORPHOLOGY Complete
2010 R21 RFA-CA-09-004 POPESCU, GABRIEL UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN LABEL FREE IMAGING OF BLOOD SMEARS AND TISSUE BIOPSIES Complete
2013 R44 RFA-CA-08-011 DUFFY, DAVID C QUANTERIX CORPORATION SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS Complete
2017 R21 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS Complete
2020 R33 RFA-CA-19-020 WEI, CHIA-LIN JACKSON LABORATORY Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer Complete
2000 R43 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2006 R33 RFA-CA-06-002 BRENT, ROGER VTT/MSI MOLECULAR SCIENCES INSTITUTE TADPOLE ASSAYS FOR THE MOLECULAR ASSESSMENT OF CANCER Complete
2009 R21 RFA-CA-08-006 BURBULIS, IAN E VTT/MSI MOLECULAR SCIENCES INSTITUTE PCR FOR CARBOHYDRATE CANCER BIOMARKERS Complete
2013 R21 RFA-CA-12-002 PAN, TINGRUI UNIVERSITY OF CALIFORNIA AT DAVIS DIGITAL ONE-DISC-ONE-COMPOUND ARRAY FOR HIGH-THROUGHPUT DISCOVERY OF CANCER-TARGE Complete
2016 R33 RFA-CA-15-003 GARRAWAY, LEVI A BROAD INSTITUTE, INC. CLINICAL IMPLEMENTATION OF SINGLE CELL TUMOR TRANSCRIPTOME ANALYSIS Complete
2019 R21 RFA-CA-18-004 ANDRES-MARTIN, LAURA NEW YORK STEM CELL FOUNDATION Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections Complete
2000 R21 PAR-99-102 OH, SEAJIN SRI INTERNATIONAL AFM BASED TECHNIQUE--ANALYZES EXPRESSION IN CANCER CELLS Complete
2002 R33 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2005 R33 RFA-CA-05-003 D'ERRICO, FRANCESCO YALE UNIVERSITY CHEMOTHERAPY WITH INJECTABLE MICRODROPLETS Complete
2008 R33 RFA-CA-07-036 VIDAL, MARC DANA-FARBER CANCER INST APPLICATION OF TECHNOLOGIES FOR INTERACTOME NETWORK ANALYSES OF CANCER MUTATIONS Complete
2011 R33 RFA-CA-10-004 JU, JINGFANG STATE UNIVERSITY NEW YORK STONY BROOK IDENTIFICATION OF POST-TRANSCRIPTIONALLY REGULATED TARGETS BY TRIP-CHIP/SEQ Complete
2015 R33 RFA-CA-14-004 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN-MADISON SCALABLE CANCER GENOMICS VIA NANOCODING AND SEQUENCING Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete
2015 R21 RFA-CA-14-003 MACCOSS, MICHAEL UNIVERSITY OF WASHINGTON SYSTEMATIC AND COMPREHENSIVE SAMPLING OF PEPTIDES IN MIXTURES BY TANDEM MASS SPECTROMETRY Complete
2018 R21 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Complete
2020 R21 RFA-CA-19-019 REVZIN, ALEXANDER MAYO CLINIC ROCHESTER A microfluidic cell culture platform for personalizing pancreatic cancer therapies NCE
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics NCE
2020 R33 RFA-CA-19-020 LEVINSON, NICHOLAS MARK UNIVERSITY OF MINNESOTA Time-resolved FRET-based allostery sensors for any protein kinase drug target NCE
2021 R21 CA20-019 NAUTIYAL, SHIVANI PRIME GENOMICS, INC. Device for Preservation of Cell Free RNA in Saliva NCE
2021 R21 CA20-017 FARIS, GREGORY W NUMENTUS TECHNOLOGIES INC. Decoding Individual Exosomes in Cancer NCE
2021 R21 CA20-017 DEININGER, MICHAEL W VERSITI WISCONSIN, INC. A Bioluminescent Assay for Direct Measurement of Sirtuin Activity in Cancer Cells NCE

Pages